Cliff Dominy
Advances in technology, especially machine learning, are increasingly enabling researchers to harness new biosignals to detect disease. In this News and Perspectives article, JMIR Correspondent Cliff Dominy reports on how vocal biomarker technology is evolving and what the future may hold.